Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where D. Lemery is active.

Publication


Featured researches published by D. Lemery.


Ultrasound in Obstetrics & Gynecology | 2007

Prenatal detection and outcome of congenital diaphragmatic hernia: a French registry-based study.

Denis Gallot; C. Boda; S. Ughetto; I. Perthus; E. Robert-Gnansia; C. Francannet; H. Laurichesse-Delmas; Jacques Jani; Karen Coste; Jan Deprest; André Labbé; Vincent Sapin; D. Lemery

To describe the true incidence, prenatal detection rate and fetal outcome of congenital diaphragmatic hernia (CDH) in a systematically registered population over an 18‐year period and to determine any change in trends over time.


European Journal of Obstetrics & Gynecology and Reproductive Biology | 2011

Twin pregnancies: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF)

Christophe Vayssiere; Guillaume Benoist; Béatrice Blondel; Philippe Deruelle; Romain Favre; Denis Gallot; Paul Jabert; D. Lemery; Olivier Picone; Jean-Claude Pons; F. Puech; E. Quarello; L. J. Salomon; Thomas Schmitz; Marie-Victoire Senat; Loïc Sentilhes; Agnes Simon; Julien Stirneman; F. Vendittelli; Norbert Winer; Yves Ville

The rate of twin deliveries in 2008 was 15.6 per 1000 in France, an increase of approximately 80% since the beginning of the 1970s. It is recommended that chorionicity be diagnosed as early as possible in twin pregnancies (Professional Consensus). The most relevant signs (close to 100%) are the number of gestational sacs between 7 and 10 weeks and the presence of a lambda sign between 11 and 14 weeks (Professional Consensus). In twin pregnancies, nuchal translucency is the best parameter for evaluating the risk of aneuploidy (Level B). The routine use of serum markers during the first or the second trimester is not recommended (Professional Consensus). In the case of a choice about sampling methods, chorionic villus sampling is recommended over amniocentesis (Professional Consensus). Monthly follow-up by a gynaecologist-obstetrician in an appropriate facility is recommended for dichorionic pregnancies (Professional Consensus). A monthly ultrasound examination including an estimation of fetal weight and umbilical artery Doppler is recommended (Professional Consensus). It is recommended to plan delivery of uncomplicated dichorionic diamniotic twin pregnancies from 38 weeks and before 40 weeks (Level C). Monthly prenatal consultations and twice-monthly ultrasound are recommended for monochorionic twins (Professional Consensus). It is reasonable to consider delivery from 36 weeks but before 38 weeks+6 days, with intensified monitoring during that time (Professional Consensus). Prenatal care of monochorionic pregnancies must be provided by a physician working in close collaboration with a facility experienced in the management of this type of pregnancy and its complications (Professional Consensus). The increased risk of maternal complications and the high rate of medical interventions justify the immediate and permanent availability of a gynaecologist-obstetrician with experience in the vaginal delivery of twins (Professional Consensus). It is recommended that the maternity ward where delivery takes place have rapid access to blood products (Professional Consensus). Only obstetric history (history of preterm delivery) (Level C) and transvaginal ultrasound measurement of cervical length (Level B) are predictive factors for preterm delivery. No study has shown that the identification by transvaginal sonography (TVS) of a group at risk of preterm delivery makes it possible to reduce the frequency of such deliveries in asymptomatic patients carrying twins (Professional Consensus). It is important to recognize signs of TTTS early to improve the management of these pregnancies (Professional Consensus). Treatment and counseling must be performed in a center that can offer fetoscopic laser coagulation of placental anastomoses (Professional Consensus). This laser treatment is the first-line treatment (Level B). In the absence of complications after laser treatment, planned delivery is recommended from 34 weeks and no later than 37 weeks (Professional Consensus). For delivery, it is desirable for women with a twin pregnancy to have epidural analgesia (Professional Consensus). The studies about the question of mode of delivery have methodological limitations and lack of power. Active management of the delivery of the second twin is recommended to reduce the interval between the births of the two twins (Level C). In the case of non-cephalic presentation, total breech extraction, preceded by internal version manoeuvres if the twins position is transverse, is associated with the lowest cesarean rates for second twins (Level C). In the case of high and not yet engaged cephalic presentation and if the team is appropriately trained, version by internal manoeuvres followed by total breech extraction is to be preferred to a combination of resumption of pushing, oxytocin perfusion, and artificial rupture of the membranes, because the former strategy appears to be associated with fewer cesareans for the second twin (Level C).


Transgenic Research | 2001

Use of transgenic mice model for understanding the placentation: towards clinical applications in human obstetrical pathologies?

Vincent Sapin; Loïc Blanchon; Anne-Françoise Serre; D. Lemery; Bernard Dastugue; Simon J. Ward

The mammalian embryo and fetus are unable to develop without a well-established, functional placenta. This transitory yet indispensable structure attaches the conceptus to the uterus and establishes the vascular connections necessary for nutrient and gaseous exchange between maternal and fetal compartments. Genetic targeting strategy allows the generation of mice lacking a specific gene. Such approaches reveal: (i) the high incidence of mutant embryonic or fetal death in utero, and (ii) the extraembryonic (placental) causes of these deaths. Due to the similarities presented between mouse and human placenta, we propose to use the potential of mouse targeting experiments as a model in order to understand human obstetrical pathologies. In this paper, we first review genes that have been demonstrated to be required in mice for implantation, choriovitelline and chorioallantoic placentation. Using examples (integrins, homeoboxs, hepatocyte growth factor or epidermal growth factor receptor...) we demonstrate the reality and efficiency of such an approach. Other candidate genes (receptor of leukemia inhibitory factor, Wnt2 or retinoic acid receptor α...) in order to understand, prevent and treat human obstetrical pathologies.


Mechanisms of Development | 2001

Co-localization of KLF6 and KLF4 with pregnancy-specific glycoproteins during human placenta development

Loı̈c Blanchon; José Luis Bocco; Denis Gallot; Anne-Marie Gachon; D. Lemery; Pierre Déchelotte; Bernard Dastugue; Vincent Sapin

Pregnancy-specific glycoproteins (PSGs) are major placental proteins essential for the maintenance of normal gestation. However, little is known about their gene expression regulation during placentation. It was previously demonstrated that the human core promoter binding protein recently renamed Krüppel-like factor (KLF) 6 binds to a highly conserved sequence within the PSG promoters and is mainly expressed in human term placenta. Here, we determined the expression pattern of the 13 other KLFs during human placental development. We demonstrate that eight KLFs exhibit specific expression patterns in human placental tissues and membranes, in favor of a functional cooperation of specific KLFs during placentation. In addition, we demonstrate that KLF6, KLF4 and PSG proteins are co-expressed in same cell types of placental villi and membranes. This experimental evidence further strengthens the potential cross talk of both transcription factors for PSG gene regulation in vivo.


Ultrasound in Obstetrics & Gynecology | 2003

Selective feticide in monochorionic twin pregnancies by ultrasound-guided umbilical cord occlusion

Denis Gallot; H. Laurichesse; D. Lemery

To evaluate the feasibility and the follow‐up of three different ultrasound‐guided procedures of selective feticide in monochorionic twin pregnancies.


Ultrasound in Obstetrics & Gynecology | 2008

Prenatal diagnosis of thrombosis of the dural sinuses: report of six cases, review of the literature and suggested management

H. Laurichesse Delmas; N. Winer; D. Gallot; K. Lopes; F. Perrotin; S. Fluncker; F. Geissler; A. M. Beaufrere; F. Vendittelli; C. Couture; D. Lemery

To describe and assess the sonographic findings, evolution and clinical implications of thrombosis of the fetal dural sinuses.


British Journal of Obstetrics and Gynaecology | 2003

Experience with three cases of laparoscopic transabdominal cervico‐isthmic cerclage and two subsequent pregnancies

Denis Gallot; Denis Savary; Hélène Laurichesse; Jean Alain Bournazeau; J. Amblard; D. Lemery

Three women with a history of recurrent miscarriages and failed vaginal cerclage had laparoscopic transabdominal cerclage. A 5 mm non‐absorbable polyether suture was placed laparoscopically at the level of the internal os as an interval procedure. All procedures were successful. All women were discharged on day 2 and none required transfusion. Two of them were pregnant within four months and were delivered by caesarean section at 38 weeks of gestation. The main interest of this technique is to avoid a laparotomy; thus, reducing the abdominal wall aggression and the recovery time.


Alcoholism: Clinical and Experimental Research | 2008

Is pregnancy the time to change alcohol consumption habits in France

Ingrid de Chazeron; Pierre-Michel Llorca; Sylvie Ughetto; F. Vendittelli; Didier Boussiron; Vincent Sapin; François Coudore; D. Lemery

BACKGROUND Although it is well known that France has a cultural history of alcohol use, no recent French data on alcohol consumption during pregnancy in a large sample are available. METHODS To determine the alcohol consumption patterns among pregnant women in France, we analyzed data from a 1-year multicenter self-survey. Sociodemographic profile, obstetrical history, neonatal data, and a self-report for assessing drinking patterns during pregnancy including AUDIT were recorded from women who delivered recently. Cases of fetal alcohol syndrome (FAS) were also reported. RESULTS A total of 837 pregnant women have described all parameters. The mean age at delivery of our sample was 29.7 years (SD = 4.8 years). A total of 52.2% of women indicated that they had consumed alcohol at least once during their pregnancy, and among abstainers 54.5% had a positive AUDIT score. Of the pregnant women who consumed alcohol, 13.7% reported at least one binge drinking episode (5 or more drinks on 1 occasion) during pregnancy. Binge drinking is significantly more frequent than regular alcohol consumption (at least 1 drink more than 1 time per week) during pregnancy. A prevalence rate of FAS of 1.8 per 1,000 live births was observed. CONCLUSIONS There is a large population of women who still drink alcohol during pregnancy, particularly in binge drinking episodes. This underlines the need to clearly inform women of childbearing age about the dangers of alcohol during pregnancy as related to all types of consumption. Moreover, acting to prevent alcohol consumption prior to pregnancy may also greatly influence prenatal drinking.


Vitamins and Hormones Series | 2007

Metabolism of Retinol During Mammalian Placental and Embryonic Development

Geoffroy Marceau; Denis Gallot; D. Lemery; Vincent Sapin

Retinol (vitamin A) is a fat-soluble nutrient indispensable for a harmonious mammalian gestation. The absence or excess of retinol and its active derivatives [i.e., the retinoic acids (RAs)] can lead to abnormal development of embryonic and extraembryonic (placental) structures. The embryo is unable to synthesize the retinol and is strongly dependent on the maternal delivery of retinol itself or precursors: retinyl esters or carotenoids. Before reaching the embryonic tissue, the retinol or the precursors have to pass through the placental structures. During this placental step, a simple diffusion of retinol can occur between maternal and fetal compartments; but retinol can also be used in situ after its activation into RA(1) or stored as retinyl esters. Using retinol-binding protein knockout model, an alternative way of embryonic retinol supply was described using retinyl esters incorporated into maternal chylomicrons. In the embryo, the principal metabolic event occurring for retinol is its conversion into RAs, the active molecules implicated on the molecular control of embryonic morphogenesis and organogenesis. All these placental and embryonic events of retinol transport and metabolism are highly regulated. Nevertheless, some genetic and/or environmental abnormalities in the transport and/or metabolism of retinol can be related to developmental pathologies during mammalian development.


Fetal and Pediatric Pathology | 1992

Pseudo-Meconium Ileus Due to Cytomegalovirus Infection: A Report of Three Cases

Pierre Dechelotte; Nicole M. Mulliez; Raymonde J. Bouvier; Philippe Vanlieferinghen; D. Lemery

We observed three cases of antenatal ileus associated with cytomegalovirus (CMV) infection of the fetus and placenta. Two were detected antenatally because of increased echogenicity of the lower abdomen. In the first fetus, the ileus was associated with abnormalities of amniotic fluid enzymes but it was transient and not present at autopsy and the CMV infection was mild, without inflammatory infiltration or necrosis. In the two others, the ileus persisted and CMV-associated lesions were severe. In all three cases the virus was demonstrable in ganglion cells or within myenteric and submucosal plexuses all along the small and large intestine; ileus was imputed to CMV, which caused a paralytic ileus, and in one fetus meconium ileus was also present. A transient episode of ileus does not indicate that the fetus is free of disease and a wide range of causes must be considered, including CMV infection as well as the more usual causes such as cystic fibrosis (CF) and Hirschsprungs disease.

Collaboration


Dive into the D. Lemery's collaboration.

Top Co-Authors

Avatar

Denis Gallot

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors

Avatar

F. Vendittelli

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

H. Laurichesse-Delmas

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Karen Coste

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

André Labbé

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

D. Gallot

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Pierre Dechelotte

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

A. Delabaere

French Institute of Health and Medical Research

View shared research outputs
Researchain Logo
Decentralizing Knowledge